This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RESTASIS 0.05% eye emulsion, a specialty medication used to treat dry eye disease. The contract has a firm fixed price of $5,424.90 and a completion date of December 6, 2024. AmerisourceBergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. The DLA is the primary funding agency for this contract, which aligns with its role in supporting the medical needs of the U.S. military and other federal healthcare programs.
Generated 3/6/25, 9:52 AM